7月15日，诺诚健华盘中上涨5.09%，报15.08港元，成交额5614.91万港元。
消息面上，生物科技板块今日集体走强，行业个股普涨。同板块中，科伦博泰生物涨9.9%，康方生物涨8.5%，信达生物涨7.5%，三生制药涨6.96%，百济神州涨2.85%。公司层面，诺诚健华近期研发进展密集：靶向CDH17的新型ADC创新药ICP-B208已完成首例患者给药，临床数据刊登国际学术期刊；此外，公司2023年科创板限制性股票激励计划归属的204.48万股新增股份于今日上市流通。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.